NCT00925730 Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion Status COMPLETED Phase PHASE4
NCT00917345 Diagnosis of Primary Aldosteronism: Comparison of Post Captopril Active Renin Concentration and Plasma Renin Activity Status UNKNOWN Phase N/A
NCT00915603 Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00908531 Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer Status TERMINATED Phase PHASE3
NCT00905242 Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients Status COMPLETED Phase PHASE4
NCT00903162 Extended Endocrine Therapy for Premenopausal Women With Breast Cancer Status COMPLETED Phase PHASE2
NCT00900146 Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients Status TERMINATED Phase PHASE2/PHASE3
NCT00896012 Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal Status COMPLETED Phase PHASE4
NCT00892398 Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of Ranibizumab Status COMPLETED Phase NA
NCT00888004 Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients Status COMPLETED Phase PHASE2
NCT00887861 Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery Status COMPLETED Phase PHASE2
NCT00881049 Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00878436 Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration Status COMPLETED Phase PHASE1/PHASE2
NCT00874211 S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Status COMPLETED Phase N/A
NCT00869999 Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00867490 Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension Status COMPLETED Phase PHASE3
NCT00865020 Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal Status COMPLETED Phase PHASE4